Home Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-ethyl-1H-imidazol-3-ium hexafluoridophos-phate(V), C9H15F6N2O2P
Article Open Access

Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-ethyl-1H-imidazol-3-ium hexafluoridophos-phate(V), C9H15F6N2O2P

  • Kun Yuan , Wan-Ming Xiong , Xu-Liang Nie ORCID logo , Da-Yong Peng ORCID logo and Jing Chen EMAIL logo
Published/Copyright: June 30, 2021

Abstract

C9H15F6N2O2P, monoclinic, P21/n (no. 14), a = 8.3781(15) Å, b = 13.970(3) Å, c = 12.904(2) Å, β = 104.500(2)°, V = 1462.3(5) Å3, Z = 4, R gt (F) = 0.0677, wR ref(F 2) = 0.1977, T = 296(2) K.

CCDC no.: 2088350

The molecular structure is shown in the figure (Atoms are shown with arbitrary radii). Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colorless block
Size: 0.21 × 0.17 × 0.14 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.26 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω
θ max, completeness: 25.5°, >99%
N(hkl) measured, N(hkl)unique, R int: 11050, 2724, 0.020
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 2028
N(param)refined: 205
Programs: Bruker [1], SHELX [2], [3], Diamond [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
C1 −0.215 (2) 0.6235 (18) 0.341 (2) 0.107 (8)
H1A −0.2679 0.6186 0.4000 0.128*
H1B −0.2162 0.5615 0.3074 0.128*
C2 −0.294 (3) 0.7010 (18) 0.2611 (17) 0.112 (8)
H2A −0.2258 0.7131 0.2130 0.168*
H2B −0.3060 0.7588 0.2988 0.168*
H2C −0.4009 0.6797 0.2212 0.168*
C3 0.0885 (5) 0.6878 (3) 0.3473 (3) 0.0744 (10)
H3 0.0904 0.7073 0.2787 0.089*
C4 0.1674 (6) 0.6492 (3) 0.5167 (3) 0.0874 (12)
H4 0.2332 0.6380 0.5851 0.105*
C5 0.0042 (7) 0.6381 (4) 0.4832 (5) 0.1069 (17)
H5 −0.0651 0.6171 0.5246 0.128*
C6 0.3859 (4) 0.7006 (2) 0.4253 (3) 0.0654 (9)
H6A 0.3879 0.7139 0.3518 0.078*
H6B 0.4534 0.6444 0.4486 0.078*
C7 0.4584 (5) 0.7843 (3) 0.4944 (3) 0.0683 (9)
C8 0.6852 (7) 0.8905 (4) 0.5296 (5) 0.1161 (18)
H8A 0.6118 0.9450 0.5239 0.139*
H8B 0.7240 0.8738 0.6047 0.139*
C9 0.8191 (10) 0.9145 (6) 0.4887 (7) 0.186 (4)
H9A 0.8884 0.8595 0.4910 0.280*
H9B 0.8810 0.9650 0.5310 0.280*
H9C 0.7798 0.9357 0.4160 0.280*
N1 −0.0432 (4) 0.6629 (3) 0.3780 (3) 0.0974 (12)
N2 0.2178 (4) 0.6806 (2) 0.4296 (2) 0.0625 (7)
O1 0.4026 (4) 0.8196 (2) 0.5618 (2) 0.0909 (9)
O2 0.5963 (3) 0.80970 (19) 0.4704 (2) 0.0791 (8)
P1 0.21382 (14) 0.92432 (7) 0.20331 (8) 0.0741 (4)
F1 0.3934 (4) 0.9605 (3) 0.2159 (4) 0.1680 (16)
F2 0.0353 (4) 0.8861 (3) 0.1873 (3) 0.1488 (14)
F3 0.1626 (4) 1.02882 (19) 0.2258 (2) 0.1221 (11)
F4 0.2675 (5) 0.8199 (2) 0.1817 (3) 0.1370 (13)
F5 0.2497 (5) 0.9010 (2) 0.3253 (2) 0.1282 (12)
F6 0.1809 (5) 0.9463 (3) 0.0801 (2) 0.1323 (12)
C2A −0.2120 (9) 0.6706 (8) 0.3010 (8) 0.111 (3)
H2AA −0.2871 0.7049 0.3340 0.133*
H2AB −0.2049 0.7045 0.2367 0.133*
C1A −0.2678 (12) 0.5757 (7) 0.2759 (10) 0.155 (4)
H1AA −0.3757 0.5770 0.2279 0.233*
H1AB −0.2723 0.5428 0.3404 0.233*
H1AC −0.1931 0.5430 0.2425 0.233*
  1. aOccupancy: 0.265(15), bOccupancy: 0.735(15).

Source of material

Ethyl bromoacetate (7.5 mL, 0.067 mol) was added dropwise to a stirred solution of 1-ethylimidazole (5.77 g, 0.06 mol) in THF (60 mL). The mixture was stirred vigorously at −5 °C for 1.5 h, then at room temperature for 5–8 h. After the reaction completed (monitored by TLC), the THF top phase was decanted and the product washed with ethyl acetate and diethyl ether three times, respectively. Then residual solvent was removed, and the product was dried in vacuo at 60 °C for 1 h to give a white powder solid in 85.5% yield. Then the intermediate (3-(2-ethoxy-2-oxoethyl)-1-ethyl-1H-imidazol-3-ium bromide) (1.32 g, 0.005 mol) and KPF6 (1.08 g, 0.0058 mol) were dissolved in water (25 mL). The mixture stirred at 80 °C for 14 h, and then cooled slowly. The crystals were obtained in 25% yield.

Experimental details

All H atoms were included in calculated positions and refined as riding atoms, with C–H = 0.90–0.97 Å with U iso(H) = 1.5 U eq(C) for methyl H atoms and 1.2 U eq(C) for all other H atoms. The ethyl group is disordered (see Table 2 and the Figure).

Comment

As a room temperature molten salt, some ionic liquids have been recognized as a new type of substance [5]. Most of them exist in liquid form at relatively low temperatures (below 100 °C) or room temperature [6]. Due to their wide electrochemical window [7], they have a wide application prospect in extraction [8], biocatalysis [9], and material synthesis [10] compared to traditional solvents. In recent years, some hexafluorophosphate ionic liquids have been extensively studied due to their superior physical and chemical properties [11], [12]. Therefore, in order to keep up with the pace of green chemistry, we are committed to find hexafluorophosphate ionic liquids with better catalytic and recycled utilization efficiency [5, 1317].

In the title structure bond lengths and angles within 3-(2-ethoxy-2-oxoethyl)-1-ethyl-1H-imidazol-3-ium and in the counter anion hexafluoridophosphate(V) are very similar to those given in the literature for 3-(2-ethoxy-2-oxoethyl)-1-vinyl-1H-imidazol-3-ium hexafluoridophosphate(V) [5], [18]. The atoms of the imidazole moiety are coplanar, and the dihedral angle of the imidazole ring and the carboxylate group is 58.8(2)°. The torsion angles of C3–N2–C6–C7, N2–C6–C7–O2, C6–C7–O2–C8, and C7–O2–C8–C9 are 116.0(3)°, −167.8(2)°, −179.9(3)° and 174.3(4)°, respectively.


Corresponding author: Jing Chen, School of Information and Engineering, Jiangxi Agricultural University, Nanchang 330045, People’s Republic of China, E-mail:

Funding source: National Natural Science Foundation of China 10.13039/501100001809

Award Identifier / Grant number: 31760193

Funding source: Natural Science Foundation of Jiangxi Province of China

Award Identifier / Grant number: 20202BABL205003

Funding source: Key Research Foundation of Education Department of Jiangxi Province of China

Award Identifier / Grant number: GJJ190181, GJJ200404

Acknowledgements

X-ray data were collected at Instrumental Analysis Center Nanchang Hangkong University, Nanchang, 330063, People’s Republic of China.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by the National Natural Science Foundation of China (No. 31760193), the Natural Science Foundation of Jiangxi Province of China (No. 20202BABL205003) and the Key Research Foundation of Education Department of Jiangxi Province of China [GJJ190181, GJJ200404].

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. APEX2, SAINT and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2009.Search in Google Scholar

2. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Search in Google Scholar PubMed

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar PubMed PubMed Central

4. Brandenburg, K. DIAMOND. Visual Crystal Structure Information System. Ver. 4.0; Crystal Impact: Bonn, Germany, 2015.Search in Google Scholar

5. Huang, T., Nie, X. L., Chen, J., Zhao, W., Xiong, W. M. Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-methyl-1H-imidazol-3- iumhexafluoridophosphate(V), C8H13F6N2O2P. Z. Kristallogr. N. Cryst. Struct. 2019, 234, 1077–1079; https://doi.org/10.1515/ncrs-2019-0273.Search in Google Scholar

6. Zhang, Q. H., Shreeve, J. M. Energetic ionic liquids as explosives and propellant fuels: a new journey of ionic liquid chemistry. Chem. Rev. 2014, 114, 10527–10574; https://doi.org/10.1021/cr500364t.Search in Google Scholar PubMed

7. Huang, T., Zhao, W., Zhang, X. H., Nie, X. L., Chen, J., Xiong, W. M. Synthesis and characterization of diimidazole-based hexafluorophosphate ionic liquids. J. Mol. Liq. 2020, 320, 114465; https://doi.org/10.1016/j.molliq.2020.114465.Search in Google Scholar

8. Matsumoto, M., Mochiduki, K., Fukunishi, K., Kondo, K. Extraction of organic acids using imidazolium-based ionic liquids and their toxicity to Lactobacillus rhamnosus. Separ. Purif. Technol. 2014, 40, 97–101.10.1016/j.seppur.2004.01.009Search in Google Scholar

9. Lutz–Wahl, S., Trost, E. M., Wagner, B., Manns, A., Fischer, L. Performance of D-amino acid oxidase in presence of ionic liquids. J. Biotechnol. 2006, 124, 163–171; https://doi.org/10.1016/j.jbiotec.2006.01.023.Search in Google Scholar PubMed

10. Cao, J. M., Fang, B. Q., Wang, J., Zheng, M. B., Deng, S. G., Ma, X. J. Ionic liquids for the convenient synthesis of functional inorganic nanomaterials. Prog. Chem. 2005, 06, 82–87.Search in Google Scholar

11. Bakkar, A., Neubert, V. Electrodeposition and corrosion characterisation of micro- and nano-crystalline aluminium from AlCl3/1-ethyl-3-methylimidazolium chloride ionic liquid. Electrochim. Acta 2013, 103, 211–218; https://doi.org/10.1016/j.electacta.2013.03.198.Search in Google Scholar

12. DePasquale, J., White, N. J., Ennis, E. J., Zeller, M., Foley, J. P., Papish, E. T. Synthesis of chiral N-heterocyclic carbene (NHC) ligand precursors and formation of ruthenium(II) complexes for transfer hydrogenation catalysts. Polyhedron 2013, 58, 162–170; https://doi.org/10.1016/j.poly.2012.10.010.Search in Google Scholar

13. Kong, J. H., Lan, Y. D., Chen, J., Huang, C. G., Xiong, W. M. Preparation and component analysis of biodiesel catalyzed by functionalized dication ionic liquid. Acta Agric. Univ. Jiangxiensis 2016, 38, 386–390.Search in Google Scholar

14. Zhou, Y. H., Huang, T., Nie, X. L., Chen, J., Xiong, W. M. Crystal structure of 3,3′-(1,2-phenylenebis(methylene))bis(1-methyl-1H- imidazol-3-ium) bis(hexafluoridophosphate), C16H20F12N4P2. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 1217–1219.10.1515/ncrs-2020-0268Search in Google Scholar

15. Xiong, W. M., Chen, J., Zhao, W., Zhou, Y. H., Jing, C., Nie, X. L. Crystal structure of 1,1′-methylenebis(3-ethyl-1H-imidazol-3-ium) bis(hexafluorophosphate(V)), C11H18F12N4P2. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 7–9; https://doi.org/10.1515/ncrs-2020-0147.Search in Google Scholar

16. Zhao, W., Liu, X. T., Wu, S. Q., Xiong, W. M., Nie, X. L. Crystal structure of 3,3′-(1,2-phenylene-bis(methylene))bis(1-ethyl- 1H-imidazol-3-ium) bis(hexafluorophosphate), C18H24F12N4P2. Z. Kristallogr. N. Cryst. Struct. 2021, 236, 545–547; https://doi.org/10.1515/ncrs-2020-0639.Search in Google Scholar

17. Huang, T., Chen, J. Z., Nie, X. L., Chen, J., Xiong, W. M. Crystal structure of 3,3′-(1,2-phenylene-bis(methylene))bis(1-vinyl- 1H-imidazol-3-ium) bis(hexafluorophosphate)(V), C18H20F12N4P2. Z. Kristallogr. N. Cryst. Struct. 2021, 236, 369–371.10.1515/ncrs-2020-0555Search in Google Scholar

18. Xiong, W. M., Huang, T., Liao, S., Chen, J., Nie, X. L. Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-vinyl-1H-imidazol-3-ium hexafluoridophosphate(V), C9H13F6N2O2P. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 1029–1031; https://doi.org/10.1515/ncrs-2020-0147.Search in Google Scholar

Received: 2021-05-18
Accepted: 2021-06-18
Published Online: 2021-06-30
Published in Print: 2021-09-27

© 2021 Kun Yuan et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of [aqua-(4-iodopyridine-2,6-dicarboxylato-κ3 O,N,O′)-(1,10-phenanothroline-κ2 N,N′)copper(II)] dihydrate, C19H16O7N3CuI
  4. The crystal structure of tetrakis(1-isopropyl-1H-imidazolium) octamolybdate, C24H44Mo8N8O26
  5. Crystal structure of catena-poly[bis(µ2-3,5-bis(1-imidazolyl)pyridine-κ2 N:N′)-(µ2-3-nitrophthalato-k3 O,O′:O″)cadmium(II)] dihydrate, C30H25N11O8Cd
  6. The crystal structure of diaqua-bis(2-(3-(1H-pyrazol-4-yl)-1H-1,2,4-triazol-5-yl)pyridine-κ2 N:N′)-bis(3,5-dicarboxybenzoato-κ1 O)cobalt(II), C38H30CoN12O14
  7. Crystal structure of the nickel(II) complex aqua-(2,6-di(pyrazin-2-yl)-4,4′-bipyridine-κ3 N,N′,N′′)-(phthalato-κ2 O,O′)nickel(II) tetrahydrate, C26H26N6O9Ni
  8. The crystal structure of 1-[5-(2-fluorophenyl)-1-(pyridine-3-sulfonyl)-1H-pyrrol-3-yl]-N-methylmethanaminium 3-carboxyprop-2-enoate, C21H20FN3O6S
  9. The crystal structure of 1,2-bis(4-pyridyl)ethane - 4,4-dihydroxydiphenylmethane (1/1), C25H21N2O2
  10. Crystal structure of bis(2-((E)-5-chloro-2-hydroxybenzylidene)hydrazineyl)methaniminium trifluoroacetate dihydrate, C34H36Cl4N10O12
  11. Crystal structure of 1-cyclopropyl-7-ethoxy-6,8-difluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, C15H13F2NO4
  12. Crystal structure of methyl 3-(1H-naphtho[1,8-de][1,3,2]diazaborinin-2(3H)-yl)benzoate, C18H15BN2O2
  13. Crystal structure of (E)-N′-(2-chloro-6-hydroxybenzylidene)-2-hydroxybenzohydrazide, C14H11ClN2O3
  14. Crystal structure of Al-rich fluorophlogopite, K1.0(Mg2.8Al0.2)(Si2.8Al1.2)O10F2
  15. The crystal structure of 4,5-diiodo-1,3-dimesityl-1H-1,2,3-triazol-3-ium hexafluoridoantimonate(V), C20H22F6I2N3Sb
  16. Crystal structure of tris(3-iodopyridin-1-ium) catena-poly[(hexachlorido-κ1 Cl)-(μ2-trichlorido-κ2 Cl:Cl)diantimony(III)], C15H15Cl9I3N3Sb2
  17. Crystal structure of methyl 2-(1H-naphtho[1,8-de][1.3.2]diazaborinin-2(3H-yl)benzoate C18H15BN2O2
  18. The crystal structure of 1,8-bis(4-methoxybenzoyl)naphthalene-2,7-diyl dibenzoate, C40H28O8
  19. Crystal structure of 2-bromo-1,3,6,8-tetramethylBOPHY (BOPHY = bis(difluoroboron)-1,2-bis((1H-pyrrol-2-yl)methylene)hydrazine), C14H15B2BrF4N4
  20. The crystal structure of (E)-3-chloro-2-(2-(2-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3
  21. Crystal structure of bis(µ2- 4-iodopyridine-2,6-dicarboxylato-κ3O:N:O′)-bis(4-iodopyridine-2,6-dicarboxylato-κ3O:N:O′)-bis(µ2-1-(4-pyridyl)piperazine-κ2N:N′)-hexa-aqua-tetra-copper(II), C46H46Cu4I4N10O22
  22. Crystal structure of poly[diaqua-(μ2-2,5-dihydroxyterephthalato-κ2O:O′)(μ2-bis(4-pyridylformyl)piperazine-κ2N:N′)cadmium(II)] dihydrate, C24H28CdN4O12
  23. Crystal structure of poly[aqua-(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2N:N′)-(μ3-2,3,5,6-tetrafluoroterephthalato-κ3O:O′:O′′)cadmium(II)], C17H14N4O5F4Cd
  24. Crystal structure of 6-(quinolin-8-yl)benzo[a]phenanthridin-5(6H)-one, C26H16N2O
  25. The crystal structure of aqua-bis(6-chloropicolinato-κ2N,O)copper(II), C12H8Cl2N2O5Cu
  26. Crystal structure of catena-poly[diaqua-bis(μ2-4,4′-bipyridyl-κ2N:N′) disilver(I)] 4-oxidopyridine-3-sulfonate trihydrate, C25H29Ag2N5O9S
  27. The crystal structure of 4-(3-bromophenyl)pyrimidin-2-amine, C10H8BrN3
  28. Crystal structure of 6-oxo-4-phenyl-1-propyl-1,6-dihydropyridine-3-carbonitrile, C15H14N2O
  29. Crystal structure of 4-(2,2-difluoroethyl)-2,4-dimethyl-6-(trifluoromethyl)isoquinoline-1,3(2H,4H)-dione, C14H12F5NO2
  30. Crystal structure of dibromido-(1-methyl-1H-imidazole-κ1N)-(3-(3-methyl-1H-imidazol-3-ium-1-yl)propanoato-κ1O)zinc(II), C11H16Br2N4O2Zn
  31. The crystal structure of 1,1′-(((2 (dimethylamino)ethyl)azanediyl)bis(methylene)) bis(naphthalen-2-olato-κ4 N,N′,O,O′)-(pyridine-2,6-dicarboxylato-N,O,O′)- titanium(IV) ─ dichloromethane (2/1), C33H29N3O6Ti
  32. The layered crystal structure of bis(theophyllinium) hexachloridostannate (IV), C14H18N8O8SnCl6
  33. The crystal structre of 3-(1-ethenyl-1H-imidazol-3-ium-3-yl)propane-1-sulfonate, C8H12N2O3S
  34. Synthesis and crystal structure of di-tert-butyl 1″-acetyl-2,2″,9′-trioxo-4a′,9a′-dihydro-1′H,3′H,9′H-dispiro[indoline-3,2′-xanthene-4′,3″-indoline]-1,3′-dicarboxylate, C39H38N2O9
  35. The crystal structure of 4-chloro-2-(quinolin-8-yl)isoindoline-1,3-dione, C17H9ClN2O2
  36. The crystal structure of 1-fluoro-4-(p-tolylethynyl)benzene, C15H11F
  37. The crystal structure of bis[4-bromo-2-(1H-pyrazol-3-yl) phenolato-κ2N,O] copper(II), C18H12Br2CuN4O2
  38. The crystal structure of poly[(μ 3-imidazolato-κ 3 N:N:N′)(tetrahydrofuran- κ 1 O)lithium(I)], C7H11LiN2O
  39. Crystal structure of N′,N′′′-((1E,1′E)-(propane-2,2-diylbis(1H-pyrrole-5,2diyl))bis(methaneylylidene))di(nicotinohydrazide) pentahydrate, C25H24N8O2·5H2O
  40. Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-ethyl-1H-imidazol-3-ium hexafluoridophos-phate(V), C9H15F6N2O2P
  41. Crystal structure of (1,10-phenanthroline-κ2N,N′)-bis(3-thiophenecarboxylato-κ2O,O′)copper(II), C22H14N2O4S2Cu
  42. The crystal structure of 2-amino-3-carboxypyridin-1-ium iodide hemihydrate, C6H8IN2O2.5
  43. Crystal structure of (E)-7-methoxy-2-((6-methoxypyridin-2-yl)methylene)-tetralone, C18H17NO3
  44. The crystal structure of [μ-hydroxido-bis[(5,5′-dimethyl-2,2′-bipyridine-κ2N,N′)-tricarbonylrhenium(I)] bromide hemihydrate, C30H26N4O9Re2Br
  45. The crystal structure of 2,5-bis(3,5-dimethylphenyl)thiazolo[5,4-d]thiazole, C20H18N2S2
  46. The crystal structure of 5-benzoyl-1-[(E)-(4-fluorobenzylidene)amino]-4-phenylpyrimidin-2(1H)-one, C24H16FN3O2
  47. Crystal structure of monocarbonyl(N-nitroso-N-oxido-phenylamine-κ 2 O,O′)(tricyclohexylphosphine-κP)rhodium(I), C25H39N2O3PRh
  48. Crystal structure of poly[bis[μ3-1,3,5-tris[(1H-imidazol-1-yl)methyl]benzene-κ3N:N′:N″]nickel(II)] hexafluorosilicate, C36H36N12NiSiF6
  49. The crystal structure of 13-(pyrazole-1-yl-4-carbonitrile)-matrine, C19H25N5O
  50. Crystal structure of 3,5-bis((E)-4-methoxy-2-(trifluoromethyl)benzylidene)-1-methylpiperidin-4-one, C24H21F6NO3
  51. The crystal structure of N,N′-(Disulfanediyldi-2,1-phenylene)di(6′-methylpyridine)-2-carboxamide, C26H22N4O2S2
  52. Crystal structure of (E)-7-fluoro-2-(4-methoxy-2-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C19H14F4O2
  53. Crystal structure of ethyl 1-(4-fluorophenyl)-4-phenyl-1H-pyrrole-3-carboxylate, C19H16FNO2
  54. The crystal structure of cis-diaqua-bis (N-butyl-N-(pyridin-2-yl)pyridin-2-amine-κ2N,N′)cobalt(II)] dichloride trihydrate, C28H44Cl2N6O5Co
  55. Crystal structure of (E)-7-methoxy-2-((6-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C18H17NO3
  56. Crystal structure of (E)-2-((3-fluoropyridin-4-yl)methylene)-7-methoxy-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
  57. The crystal structure of 6-bromohexanoic acid, C6H11BrO2
  58. The crystal structure of 4-chloro-thiophenol, C6H5ClS
  59. The crystal structure of 4-bromobenzyl chloride, C7H6BrCl
  60. The crystal structure of di-tert-butyl dicarbonate, C10H18O5
  61. The crystal structure of (2-(4-chlorophenyl)-5-methyl-1,3-dioxan-5-yl)methanol, C12H15ClO3
  62. The crystal structure of the co-crystal: 2-hydroxybenzoic acid – N′-(butan-2-ylidene)pyridine-4-carbohydrazide, C10H13N3O·C7H6O3
  63. Crystal structure and anti-inflammatory activity of (E)-7-fluoro-2-((5-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
  64. Crystal structure of (E)-7-fluoro-2-((6-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
  65. Crystal structure of 1,1′-(butane-1,4-diyl)bis(3-propyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C32H56F24N8P4
  66. The crystal structure of dichlorido-bis(3-methyl-3-imidazolium-1-ylpropionato-κ2)-cadmium(II), C14H20CdCl2N4O4
  67. Crystal structure of 1-(2-cyanobenzyl)-3-cyano-4-phenyl-4-(2-cyanobenzyl)-1,4-dihydropyridine monohydrate, C56H42N8O
  68. The crystal structure of 3-(carboxymethyl)-1-ethenyl-1H-imidazol-3-ium chloride, C7H9N2O2Cl
  69. The crystal structure of adamantylmethoxydiphenylsilane, C23H28OSi
  70. Redetermination of the crystal structure of (2E,4Z,13E,15Z)-3,5,14,16-tetramethyl-2,6,13,17-tetraazatricyclo[16.4.0.07,12]docosa-1(22),2,4,7,9,11,13,15,18,20-decaene, C22H24N4
  71. Crystal structure of (E)-7-hydroxy-2-((6-methoxypyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C17H15NO3
  72. Crystal structure of catena-poly[diaqua-bis(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2 N:N′)cobalt(II)] dinitrate, C18H28N10O8Co
Downloaded on 15.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0194/html
Scroll to top button